Mostafa Eltobgy
Overview
Explore the profile of Mostafa Eltobgy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Badr A, Daily K, Eltobgy M, Estfanous S, Tan M, Chun-Tien Kuo J, et al.
Brain Behav Immun
. 2024 May;
119:919-944.
PMID: 38718909
Neuroinflammation and accumulation of Amyloid Beta (Aβ) accompanied by deterioration of special memory are hallmarks of Alzheimer's disease (AD). Effective preventative and treatment options for AD are still needed. Microglia...
2.
Daily K, Badr A, Eltobgy M, Estfanous S, Whitham O, Tan M, et al.
Alzheimers Res Ther
. 2024 Feb;
16(1):29.
PMID: 38326859
Alzheimer's disease (AD) is the sixth leading cause of death in the USA. It is established that neuroinflammation contributes to the synaptic loss, neuronal death, and symptomatic decline of AD...
3.
Xu J, Zhang Y, Qu P, Shamseldin M, Yoo S, Misny J, et al.
Proc Natl Acad Sci U S A
. 2023 Oct;
120(41):e2220403120.
PMID: 37796985
As SARS-CoV-2 variants of concern (VoCs) that evade immunity continue to emerge, next-generation adaptable COVID-19 vaccines which protect the respiratory tract and provide broader, more effective, and durable protection are...
4.
Daily K, Badr A, Eltobgy M, Estfanous S, Whitham O, Tan M, et al.
bioRxiv
. 2023 Sep;
PMID: 37693600
Alzheimer's Disease (AD) is the 6th leading cause of death in the US. It is established that neuroinflammation contributes to the synaptic loss, neuronal death, and symptomatic decline of AD...
5.
Shamseldin M, Kenney A, Zani A, Evans J, Zeng C, Read K, et al.
J Immunol
. 2023 Mar;
210(9):1257-1271.
PMID: 36881867
Vaccines against SARS-CoV-2 that induce mucosal immunity capable of preventing infection and disease remain urgently needed. In this study, we demonstrate the efficacy of Bordetella colonization factor A (BcfA), a...
6.
Abdelazeem B, Hamdallah A, Rizk M, Abbas K, El-Shahat N, Manasrah N, et al.
PLoS One
. 2023 Jan;
18(1):e0279128.
PMID: 36649255
Background: Surveys are an effective method for collecting a large quantity of data. However, incomplete responses to these surveys can affect the validity of the studies and introduce bias. Recent...
7.
Abdelazeem B, Abbas K, Amin M, El-Shahat N, Malik B, Kalantary A, et al.
PLoS One
. 2022 Apr;
17(4):e0267534.
PMID: 35452488
Background: Recruitment plays a vital role in conducting randomized control trials (RCTs). Challenges and failure of proper recruitment lead to early termination of trials. Monetary incentives have been suggested as...
8.
Abdelazeem B, Shehata J, Abbas K, El-Shahat N, Malik B, Savarapu P, et al.
PLoS One
. 2022 Apr;
17(4):e0266243.
PMID: 35363823
Background: Roxadustat (ROX) is a new medication for anemia as a complication of chronic kidney disease (CKD). Our meta-analysis aims to evaluate the efficacy and safety of ROX, especially on...
9.
Badr A, Eltobgy M, Krause K, Hamilton K, Estfanous S, Daily K, et al.
Front Cell Infect Microbiol
. 2022 Mar;
12:819554.
PMID: 35252032
Cystic fibrosis (CF) human and mouse macrophages are defective in their ability to clear bacteria such as . The autophagy process in CF (F508del) macrophages is halted, and the underlying...
10.
Beyer S, Sebastian N, Prasad R, Chu J, Liu K, Madan K, et al.
Surg Neurol Int
. 2022 Jan;
12:588.
PMID: 34992905
Background: Ossifying fibromyxoid tumor (OFMT) is a rare musculoskeletal soft-tissue neoplasm of uncertain histogenesis most frequently occurring in the lower extremities. Conventionally, considered benign, these tumors are often managed by...